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Introduction
The "linear parametric neurotransmitter PET" (lp-ntPET) method was introduced (Normandin et al., 2012; Kim et al., 2014) to characterize the temporal patterns of time-varying neurotransmitter release induced by drug stimulus from dynamic PET data. We used this novel analysis tool previously to estimate DA response to cigarette smoking in the PET scanner. It allowed us to identify a sex difference in the brain's DA signature of cigarette smoking . We found that nicotine-dependent men responded rapidly and consistently to cigarette smoking in the right ventral striatum, the locus of the reinforcement effect of drugs such as nicotine. Women did not. A secondary finding was that, women responded faster than men in a part of the dorsal putamen, which has been implicated in habit formation (Porrino et al., 2004; Everitt and Robbins, 2013) . These findings are consistent with the established notions that men smoke primarily for the reinforcing drug effect of nicotine (Perkins et al., 2001) , while women tend to smoke cigarettes for other reasons, such as to alleviate stress and negative mood or out of habit.
None of the temporal differences that we observed could have been discovered without lp-ntPET. To make best use of this novel analysis tool to characterize neurotransmitter response to stimulus, the sensitivity of lp-ntPET to detect such responses must be maximized. We experienced several challenges that may have weakened the power of lp-ntPET. One obstacle was getting sufficient radioactivity dose. In our smoking study, our tracer delivery protocol was set to deliver 20mCi of [ 11 C]raclopride in a 90 min bolus plus constant infusion scan with a K bol of 105 min. It is quite a demanding burden on us to produce sufficient radioactivity following this protocol. Lower radioactivity dose could lead to greater noise and lower sensitivity of our method. Another challenge was the high noise level of voxel-by-voxel analysis. We believe lower noise in the voxel-level time activity curves (TACs) from the PET data will lead to more reliable parameter estimation. In addition, to better inform the neuroimaging community of the use of lp-ntPET, two remaining design parameters are the timing of the task and the duration of the scan.
Our goal in this study was to address these challenges by optimizing the experimental design and image processing procedure to achieve maximum sensitivity of lp-ntPET in detecting transient neurotransmitter response induced by stimulus. To this end, we designed a series of simulation studies to assess the impact of the following factors on the sensitivity of lp-ntPET: (1) tracer delivery protocol, (2) preprocessing for image denoising, (3) timing of the challenge/task, (4) duration of the PET scan, and (5) dose of the radiotracer.
Among many possible applications, one application of lp-ntPET is to probe the short-lived DA response to cigarette smoking. Smoking remains the leading preventable cause of death in the US. Quitting smoking is extremely hard and current therapies to aid in smoking cessation are not effective enough. The primary addictive chemical in tobacco is nicotine. Nicotine, along with most drugs of abuse, has been shown to cause DA release (Di Chiara and Imperato 1988) . Dopamine has been critically implicated in the reinforcing effects of nicotine and tobacco cigarette smoking. A number of PET imaging studies attempted to measure smoking-induced striatal DA release (Barrett et al., 2004; Brody et al., 2004 Brody et al., , 2006 Scott et al., 2007) , but with highly variable results. We believe these inconsistencies observed were due to reliance on conventional PET methods that were really only appropriate to detect sustained DA release ) (e.g., in response to amphetamine administration). But, the DA response to cigarette smoking is brief (lasting only minutes).
In addition, it has been suggested that a drug's addictive liability may be dependent on the timing of DA release (Volkow and Swanson, 2003) , something that cannot be assessed in humans with conventional PET analysis methods. To probe the short-lived neurotransmitter response to drug stimulus in PET data on a voxel-by-voxel basis, we developed lp-ntPET (Morris et al., 2005 Normandin and Morris, 2008; Normandin et al., 2012; Kim et al., 2014) . This method allows us to characterize the important temporal patterns of transient DA release with parametric images of DA parameters and "DA movies" of the brain from [
11 C]raclopride PET scans. The strength of lp-ntPET over conventional methods has two main parts. One, it is designed to detect short-lived time-varying neurotransmitter response, and is thus ideal for imaging the DA response to cigarette smoking. Two, the resulting parametric images contain timing information about DA activation that was not previously measurable in vivo. By optimizing the experimental design and image processing procedure to maximize the sensitivity of the lp-ntPET method to detect short-lived neurotransmitter response, we found in our simulation studies: 1. a tracer delivery protocol that saves radioactivity, 2. a preprocessing algorithm that reduces noise, 3. an optimal timing of the task that yields maximum sensitivity, 4. a shorter scan duration that preserve performance, and 5. a minimum dose of the radiotracer to maintain a consistently high sensitivity. The application of lp-ntPET is not limited to imaging DA release or cigarette smoking. This study established the framework to optimize the experimental design for use with lp-ntPET analysis in a broader field of neuroimaging research to detect neurotransmitter responses to drugs or even behavioral tasks.
Materials and methods

Lp-ntPET model
Eq. (1) shows the operational equation of lp-ntPET (Normandin et al., 2012) . The first three terms are the MRTM model (Ichise et al., 2003) that considers endogenous DA to be time-invariant. The additional term (dashed in Eq. (1)) describes the pattern of transient DA release induced by smoking/drug challenge by extending the LSRRM of Alpert et al. (2003) using a basis function approach.
(1) C T and C R are the concentrations in the target and reference region, respectively. R 1 is delivery ratio, k 2 is a transfer rate constant between the free compartment and the plasma, and k a 2 is the apparent transfer rate constant between the target tissue (taken as one compartment) and the plasma. 
The variable t D is a response start time (relative to the start of the tracer), t P is a peak response time (relative to the start of the tracer), α represents sharpness of the function, and β is the exponential time constant. During the curve fitting process, only one of the response functions from the library is used for a given fit. The response function with the best fit is chosen.
The lp-ntPET model is applied voxel-by-voxel to all the PET data. Using an F test, at each voxel the fit with lp-ntPET is compared to the fit with MRTM. This generates an F statistics map as a measure of the improvement of the fit achieved by lp-ntPET over MRTM, corrected by degrees of freedom. The F statistics map is first thresholded by an F statistics value that translates to a p-value < 0.05 and then thresholded by a cluster size threshold to correct for multiple comparisons and controls the false positive rate < 10%. The remaining voxels after the thresholding processes are identified to contain significant DA release. The details of the theory and implementation of lp-ntPET have been described by Kim et al. (2014) .
Simulations
Noisy and noiseless striatal [
11 C]raclopride time activity curves (TACs) with DA release at various time points were simulated for scan durations of 90 and 75 min in 3-min frames. To best represent the real data, our simulated noisy data used a similar noise level as was found in voxel-level TACs from a real human [ 11 C]raclopride scan. The noiseless TACs were simulated using the full 'ntPET' model (Morris et al., 2005) , which is a nonlinear model of tracer binding to a receptor in the presence of a time-varying endogenous competitor. The simulations were implemented in Matlab (R2012b, MathWorks, Inc., Natick, MA) using modeling functions provided by a library of COMKAT (Muzic and Cornelius, 2001 ).
Input function
Different input functions were used for simulating different injection protocols. (1) Input function for simulating bolus data. The simulated Bolus data used an input function (Fig. 1a) taken from (Fig. 1b) with a K bol =105min, a scan duration T=90min and delivered dose of 20mCi (equivalent to a dose of 29.36 mCi at the beginning of the scan) was calculated using the Eq. (3) (Carson et al., 1993) , (Morris et al., 1995) . (1) DA parameters for null data. To simulate null data, the basal DA level was set as 100 nM, and the peak DA level = 0 (no DA elevation above the basal DA level) (Fig. 2a) . (2) DA parameters for smoking data. To simulate smoking data, the basal DA level was set as 100 nM, and the peak DA level = 200 nM above basal level (Fig. 2b) . A series of timing parameters were applied to the gamma-variate function to simulate varied start time of cigarette smoking during the scan with takeoff time t D = [25, 35, 45, 55] min, peak time t P = t D +10 min, and sharpness α=1.
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Noise
Gaussian noise was added to the noiseless target tissue TACs ( Fig. 2c, d , g, h) with zero mean and the following standard deviation corresponding to the ith time frame [Eq. (5)] .
The scale factor μ determines the noise level, C t ( ) T i is the target tissue tracer concentration of the ith frame in the simulated noiseless TAC, λ is the decay constant for Carbon-11, and t Δ i is the frame length of the ith time frame. To reflect the noise level in the real data, the scale factor μ was set at 0.8 to achieve the same mean coefficient of variation as that in a 90-min B/I [ 11 C]raclopride PET rest scan acquired in the HRRT PET scanner (Siemens/CTI, Knoxville, TN) in a human subject with a 20mCi delivered radioactivity. The voxel-level coefficient of variation in the real data was determined from the ratio of the standard deviation to the mean of the last 15 min of [ 11 C]raclopride PET concentration in each individual voxel within the ventral-striatum region. Then the mean coefficient of variation was calculated by fitting a Gaussian to the voxel-level coefficient of variation in all voxels. To validate that the noise level in the simulated noisy data (Fig. 2e , f, i, j) was similar to that in the real data, the distributions of F statistics ( Fig. 3 ) after applying lp-ntPET were compared between the two datasets following procedures described in Kim et al., 2014 .
Creating a 4D phantom
To create a 4D phantom, simulated noisy TACs were placed into a 3D striatal template which contains 4 coronal slices and 1004 voxels in the MNI template space corresponding to the precommissural striatum (ventral striatum, dorsal caudate, and dorsal putamen) (Martinez et al., 2003) . (1) Null phantom. To create a single 4D null phantom, 1004 noisy TACs of null data were simulated and assigned to each of the 1004 voxels in our striatal template (Fig. 4a ). For each injection protocol, 100 null phantoms were created. (2) Smoking phantom. To create a smoking phantom, 4 clusters ( Fig. 4b ) of different sizes: [16, 32, 64, 128] voxels within the striatal template were filled with noisy TACs of smoking data, while the remaining voxels ( Fig. 4c ) in the template were filled with noisy TACs of null data. Clusters were 3D. They existed in all 4 slices of the 3D striatal template. Thus we simulated 4 local volume of activation within the striatal volume of interest. For each smoking study paradigm, 100 smoking phantoms were generated. b. An example of simulated DA curve for smoking data (DA takes off at 35min, peaks at 45min). c. Simulated noiseless striatal null data for a Bolus study. d. Simulated noiseless striatal smoking data for a Bolus study. e. Simulated noisy striatal null data for a Bolus study. f. Simulated noisy striatal smoking data for a Bolus study. g. Simulated noiseless striatal null data for a B/I study. h. Simulated noiseless striatal smoking data for a B/I study. i. Simulated noisy striatal null data for a B/I study. j. Simulated noisy striatal smoking data for a B/I study. 
HYPR De-noising
The simulated 4D phantoms were first processed by "HighlY constrained backPRojection" (HYPR) (Christian et al., 2010) . The HYPR processing is an image de-noising algorithm that reduces noise in the PET TACs while preserving critical temporal patterns in the data. The algorithm was implemented in this study using a 3 x 3 x 3 voxels 3D boxcar smoothing filter, and the entire time series of data as the composite image.
Modeling
The lp-ntPET model was applied to fit the PET data voxel-by-voxel in all phantoms we created (pre and post HYPR de-noising). The MRTM model was also applied to fit the same data. The weighted residual sum of squares (WRSS) of both fits in all voxels were recorded. For lp-ntPET fits, we used the following discrete set of parameter values for the gamma-variate response function for characterizing patterns of DA response induced by smoking a cigarette. The sharpness parameter α were set to include 3 possible values: 0.25, 1, and 4. Response start times (t D ) were set between (smoking time -5 min) to (smoking time + 15 min) in increments of 1.5 min. Peak response times (t P ) were set between (t D + 1.5 min) and (total scan time -5 min) in increments of 1.5 min. .
F-test thresholding
An F statistics map (Figs. 5a, 6a) was generated with the F statistics calculated [Eq. (6)] for each voxel in the phantom, where WRSS i and p i are the WRSS and number of parameters, respectively, for model i, and n is the number of data points in a PET TAC. The F statistics, in this case, is a measure of the improvement of the fit achieved by lp-ntPET over MRTM, corrected by degrees of freedom. The F statistics map was thresholded by the F statistics value that translates to a p-value < 0.05. This step generated the Preliminary Significance Mask (Figs. 5b, 6b ) which was a binarized mask in which 1 represents presence of significant DA release in a given voxel.
Cluster-size thresholding
To correct for multiple comparisons, a cluster-size threshold was applied to the Preliminary Significance Mask to generate the Final Significance Mask (Figs. 5c, 6c) . The cluster-size threshold was determined for each study protocol from simulated null data . For each protocol, the 100 simulated noisy null phantoms were processed, yielding 100 Preliminary Significance Masks containing clusters of various sizes that were identified as containing significant DA release in the null data, and were therefore false positive clusters. A first-pass cluster size threshold was determined so that 99% (Fig. 5d ) of the total false positive clusters in the 100 significance maps were eliminated. The cluster size threshold was further adjusted to ensure that 90 out of 100 null phantoms were completely free of false Fig. 5 . Processing steps to determine cluster size threshold that corrects for multiple comparisons and controls the false positive rate to be less than 10%. a. The F statistics map generated from a null phantom. b. The Preliminary Significance Mask thresholded by the F statistics value that translates to a p-value < 0.05. c. The Final Significance Mask thresholded by the cluster size threshold that corrects for multiple comparisons and controls the false positive rate to be less than 10%. d. The histogram of all false positive clusters in the 100 Preliminary Significance Masks generated from 100 simulated null phantoms. A first-pass cluster size threshold was determined so that 99% of the false positive clusters in the 100 Preliminary Significance Masks were eliminated. e. The cluster size threshold was further adjusted to ensure that 90 out of 100 Final Significance Masks from simulated null phantoms were completely free of false positive clusters.
positive clusters (Fig. 5e ).
Metrics for comparing detection sensitivities
For each protocol, the 100 simulated noisy smoking phantoms were processed, with corresponding cluster size threshold applied, yielding 100 Final Significance Masks (Fig. 6d) containing clusters that were identified to contain significant DA release in the smoking data. We have defined sensitivity in two ways to fully characterize the performance of our method.
Mean voxel-by-voxel sensitivity
The 100 binary final significance masks (Fig. 6d) were summed ( Fig. 6e) and filtered by the binary template of true clusters of activation (Fig. 6f) to generate a sensitivity map (Fig. 6g) . Each voxel in the sensitivity map contains a sensitivity value ranging from 0 to 100 representing the number of smoking phantoms out of 100 phantoms in which DA activation was detected at a given voxel. The Mean Voxel-byVoxel (MV) Sensitivity was calculated as the mean of the voxel-by-voxel sensitivity values across all voxels containing a true cluster of activation [Eq. (7)] (Fig. 7) . By rearrangement, the MV Sensitivity can be interpreted as the Mean Percent of Spatial Extent in the region containing true DA activation that is detected, averaged over 100 
N Voxels is the number of voxels in a true cluster of activation, Sensitivity Voxel i represents the number of smoking phantoms out of 100 phantoms in which DA activation was detected at the i th voxel, and
is the binary value with 1 representing 'activation' detected and 0 representing 'no activation' detected at the i th voxel in the j th simulated smoking phantom.
Binary Cluster Detection Sensitivity
The Binary Cluster Detection (BC) Sensitivity was calculated as the number of simulated phantoms with final significance masks that partially overlapped with the mask of clusters in the true phantom (Fig. 8) . This definition asked the "yes" or "no" question: was a given cluster of activation detected in a simulated phantom. The answer was "yes" when as long as part of the cluster in the true phantom was identified to contain DA release in the simulated phantom. The BC Sensitivity counted the number of simulated phantoms that were positively detected out of 100 simulated phantoms and thus represents the percent chance of a true DA activation being detected without regard to a perfect recovery of all voxels in the cluster.
Study design
We designed 5 different simulation studies to address 5 impacting factors on the sensitivity of lp-ntPET. Study 1. Tracer Delivery. A Bolus and a B/I dataset were simulated and analyzed to compare the sensitivity of lp-ntPET in detecting transient DA release between these two practices of tracer delivery. The Bolus paradigm was simulated as a Bolus injection of 20mCi of [ 11 C]raclopride with a 90min scan duration. The B/I paradigm was simulated with a 90min scan duration, a K bol of 105min and total delivered dose of 20mCi. In both studies, the smoking-induced DA release was simulated to take off at 35min after the beginning of the injection. Study 2. Pre-processing. The Bolus and B/I datasets in Study 1 were each processed twice following two different procedures to assess the impact of HYPR de-noising on the sensitivity of lp-ntPET in detecting transient DA release. In one case, there was no pre-processing before fitting data with the lp-ntPET model. In the second case, phantom data were pre-processed with the HYPR de-noising algorithm prior to data fitting. In our implementation of HYPR, we used a (3 x 3 x 3 voxels) 3D boxcar smoothing filter, and a time-averaged composite image generated from the entire time series of data. Study 3. Optimal Timing of Task. A series of Bolus (Fig. 9b) and B/I (Fig. 9c) datasets were simulated to include DA activation starting at one of four different time points during the scan to determine the optimal timing to start the smoking task. The DA activations were simulated as gamma variate functions with take off time t D = [25, 35, 45, 55] min. Peak time was determined, accordingly, as t P =t D +10min (Fig. 9a) . Study 4. Scan Duration. Another series of datasets were simulated to include DA activation with all the same DA parameters as in Study 3, but with only a 75min scan duration. Study 5. Minimum Radioactivity Dose. A series of Bolus studies were simulated to represent Bolus injections of 10mCi, 12mCi, 14mCi, 16mCi, 18mCi and 20mCi of [ 11 C]raclopride with a 75min scan duration (Fig. 9d) to determine the minimum Bolus dose that would provide acceptable sensitivity. Fig. 8 . Calculation of Binary Cluster Detection (BC) Sensitivity. The BC Sensitivity asked the "yes" or "no" question: was a given cluster of activation detected in a simulated phantom. The answer was "yes" (label as "1") when as long as part of the cluster in the true phantom was identified to contain DA release in the simulated phantom. The BC Sensitivity counted the number of simulated phantoms that were positively detected (the number of "1"s) out of 100 simulated phantoms.
Results
Tracer delivery
The sensitivities of lp-ntPET in detecting the simulated DA release in the Bolus vs. B/I study without HYPR processing are shown in Fig. 10 (green lines) . With the same delivered radioactivity dose, the Bolus paradigm yielded lower MV Sensitivity vs. the B/I paradigm in all 4 simulated clusters containing DA release (green lines in Fig. 10 a vs.  b) . The BC Sensitivity (green lines in Fig. 10 c vs. d, Supplementary Table S1) were the same in the 3 largest clusters for Bolus and B/I: 100% for the 64-voxel and 128-voxel clusters, and 99% for the 32-voxel cluster. In the smallest cluster (16 voxels), the BC Sensitivity for a Bolus study was lower than a B/I study (53% vs. 71%).
Pre-processing
The sensitivities in both Bolus and B/I studies when the data are pre-processed by the HYPR de-noising algorithm are shown by the orange lines in Fig. 10 . HYPR processing dramatically improved the MV Sensitivity in both paradigms ( Fig. 10 orange lines vs. green lines, Fig. 11 bottom row vs. top row). In the Bolus paradigm, HYPR increased the MV Sensitivity from 32.2% to 60.0% (Fig. 10a ) in the smallest cluster containing 16 voxels with true DA activation, and from 62.2% to 98.8% in the biggest cluster (128 voxels). In the B/I paradigm, HYPR improved the MV Sensitivity from 49.5% to 62.9% (Fig. 10b ) in the smallest cluster (16 voxels), and from 71.6% to 99.2% in the biggest cluster (128 voxels). When the data in both paradigms were pre-processed by HYPR, the Bolus paradigm yielded similar MV Sensitivity as the B/I (orange lines in Fig. 10 a vs. b) , and almost identical BC Sensitivity as the B/I (orange lines in Fig. 10 
Optimal timing of task
Tables 1-4 presents the influence of different takeoff times of simulated DA activation (as a representation of the start time of a smoking task) on the sensitivity in 90min Bolus and B/I studies. In the 90min Bolus paradigm, the MV Sensitivity was highest when DA started to rise from baseline at 35 or 45min following tracer injection ( Fig. 12a and Table 1 ). The highest BC Sensitivity for the 16-voxel cluster was 77% for a DA curve that took off at 45min, 100% for the 32-voxel cluster when DA took off at 35, 45 or 55min, and 100% for clusters of 64 and 128 voxels regardless of DA takeoff times (Table 2 ). In the 90min B/I paradigm, the maximum MV Sensitivity was achieved when DA took off at 45min (Fig. 12b and Table 3 ). The highest BC Sensitivity for the 16-voxel cluster was 84% when DA took off at 55min, 100% for the 32-voxel cluster when DA took off at 35, 45 or 55min, and 100% for the other 2 clusters regardless of DA takeoff times (Table 4) .
Scan duration
The sensitivity in 75min Bolus and B/I studies with different takeoff times for DA is shown in Tables 5-8. In the 75min Bolus paradigm, the maximum MV Sensitivity was achieved when DA took off at 35min (Fig. 12c and Table 5 ). The highest BC Sensitivity for the 16-voxel cluster was 81% for a DA curve that took off at 35min, 100% for the 32-voxel cluster when DA took off at 35min or 45min, and 100% for the 64-voxel and 128-voxel clusters regardless of DA takeoff times (Table 6 ). In the 75min B/I paradigm, the maximum MV Sensitivity occurred when DA took off at 35min (Fig. 12d and Table 7 ). The highest BC Sensitivity for the 16-voxel cluster was 86% when DA took off at 35min, 100% for the 32-voxel cluster when DA took off at 25, 35 or 45min, and 100% for the 64-voxel and 128-voxel clusters regardless of DA takeoff times (Table 8) .
The comparison of 75min to 90min scan duration revealed that the highest MV Sensitivity and BC Sensitivity achieved in a 75min scan (Tables 5-8 ) was as good as that in a 90min scan (Tables 1-4 ). The MV Sensitivity and BC Sensitivity for a DA curve that took off at 55min were much smaller for a 75min scan (last row in Tables 5-8) as compared to a 90min scan (last row in Tables 1-4) . 
Minimum radioactivity dose
In 75min Bolus studies with different delivered radioactivity doses, the MV Sensitivity for activated clusters of all sizes gradually decreased as lower and lower delivered doses were simulated (Supplementary  Table S3 and Fig. S1a ). The BC Sensitivity for the 16-voxel cluster was almost unchanged when the dose decreased from 20mCi to 16mCi (from 81% to 80%), but started to drop as the dose was lowered to 14mCi (76%), and was very low at 10mCi (55%) (Supplementary Table  S4 and Fig. S1b ). For the 3 largest clusters, the BC Sensitivity was constantly 100% when the dose dropped from 20mCi to 10mCi.
Cluster size threshold
In order to maintain all the same false positive rate to be less than 10% in the overall method, the cluster size threshold was varied across different study paradigms. The cluster size threshold was similar for Bolus and B/I without HYPR pre-processing. HYPR increased the cluster size threshold for Bolus from 11 to 28 voxels, and for B/I from 12 to 36 voxels in smoking studies containing DA activation that took off at 35min with a 90min scan duration and 20mCi of delivered radioactivity. As an example to illustrate the number of clusters thresholded out after first-and second-pass, for the 90min B/I studies with HYPR applied in the 100 simulated null phantoms, the total number of false positive clusters was 2693, the first-pass threshold was set at 29 voxels so that only 26 ( < 1% of 2693) false positive clusters were retained, i.e. 99% of false positive clusters were eliminated. The surviving 26 false positive clusters were distributed among 22 of the 100 null phantoms. The second-pass threshold was increased to 36 voxels, so that only 9 out of the 100 phantoms contained 1 false positive cluster, thus satisfying our goal that < 10% phantoms have any false positive cluster. As the start time of task went later into the scan, the cluster size threshold became smaller. For example, the cluster size thresholds for Bolus studies containing DA activation that took off at [25, 35, 45, 55] min were [31, 28, 23, 15] voxels. The 75min scan required a smaller cluster size threshold than a 90min scan (e.g., for a Bolus study containing DA activation that took off at 35min, the cluster size threshold was 17 voxels for a 75min scan duration as compared to 28 voxels for a 90min scan duration). As the Bolus tracer dose was lowered from 20mCi to 10mCi, the cluster size threshold was generally unchanged until the dose reached 10mCi (17 voxels for [20, 18, 16, 14, 12] mCi Bolus doses, and 18 voxels for 10mCi).
Discussion
Bolus as an alternative to B/I
Our main finding was that a Bolus yielded equivalent sensitivity as a B/I paradigm with the same delivered radioactivity dose provided that HYPR was applied. This finding from simulations provides important guidance for experimental design of future lp-ntPET experiments on smoking or similar behavioral tasks, especially when radioactivity dose may be limited. For a B/I injection of [
11 C]raclopride with a delivered dose=20mCi, a Kbol=105min and a scan duration of 90min, the required pre-scan dose must be at least 29.4mCi. When the radioactivity produced by the radiochemistry lab falls below 29.4mCi prescan, an alternative paradigm, a Bolus of 20mCi of [ 11 C]raclopride could be administered without sacrificing the sensitivity of the lpntPET method. This finding suggests that when a high enough pre-scan dose for the B/I paradigm can not be consistently produced, the Bolus paradigm should be considered as an acceptable alternate design.
Contribution of HYPR De-noising
We found that HYPR dramatically improved the MV Sensitivity for both paradigms and the BC Sensitivity in the Bolus paradigm. We attribute improved sensitivity with HYPR to the effect of noise reduction in the TACs. In fact, we have previously shown the power of HYPR in reducing noise in the TACs of [
11 C]raclopride PET data on the voxel level (Wang et al., 2012) . In addition to HYPR, we also evaluated the impact of simple spatial smoothing on detection sensitivity and temporal precision of the recovered response profile. The results (see Supplementary text, Figs. S2-S4 and Table S5 ) support the selection of HYPR over simple spatial smoothing.
Optimal timing of the smoking task
Our results comparing smoking challenges starting at different time points during the scan favor a 45 min start in a 90 min scan and 35 min start in a 75 min scan as the optimal timing. The lp-ntPET analysis achieved its maximum sensitivity at these time points especially for small areas of activation (e.g., the cluster of 16 voxels in the true phantom). In much bigger areas of activation, the success rate of lpntPET in detecting transient DA release was consistently high (99%-100% BC Sensitivity) and insensitive to start time of smoking.
Scan duration
We found that the maximum sensitivity in a 75min scan was as good as that in a 90min scan. This suggests that the duration of a smoking PET scan can be shortened from 90min to 75min. The advantage of shortening the scan duration is probably based on the fact that TACs in a 75min scan are less noisy than those in a 90min scan with the same delivered radioactivity dose and can thus reduce false positive findings. It should be noted that the 75min scan showed lower sensitivity compared to a 90min scan if DA takeoff was late (e.g., 55min). This was probably because as DA took off later, less perturbation to the shape of TACs introduced by the DA release was captured in the scan data. The difference between fits with MRTM and lp-ntPET became less pronounced. This suggests that late start time of tasks should be avoided when using a shorter scan.
The minimum radioactivity dose
Our results comparing different doses of the radiotracer suggest a practical minimum dose of 16mCi in the bolus paradigm. Although the mean percent of detected spatial extent (reflected by the MV Sensitivity) gradually decreased as the delivered dose was lowered, the overall chance of detecting an activated region (the BC Sensitivity) was unchanged when the dose decreased from 20mCi to 16mCi, but started to drop as the dose was lowered to 14mCi. Doses lower than 16mCi of bolus injection could lead to underestimation of DA activation. That is, actual DA release in subjects who received lower than 16mCi of [ 11 C]raclopride would be detected less frequently due to lower sensitivity of the method.
Cluster size threshold
The cluster size threshold was intentionally varied across different study paradigms. With these cluster size thresholds applied to their corresponding study paradigms, the false positive rate was maintained to be constant ( < 10%) in the overall method. Although the cluster size threshold was increased by HYPR for Bolus from 11 to 28 voxels, and for B/I from 12 to 36 voxels (in smoking studies containing DA activation that took off at 35min with a 90min scan duration and 20mCi of delivered radioactivity), the sensitivity was still higher when HYPR was applied. That is, even with a larger cluster size threshold, HYPR allowed us to achieve higher sensitivity. This was because HYPR added spatial correlation to the neighboring voxels of true clusters containing DA activation, which effectively enlarged the areas of activation.
Limitations and possible uses
Only one shape of the DA response function was used in our simulation study. The peak height of DA activation was simulated to be 200% above the basal level. This peak height was picked based on results from previous microdialysis studies, which showed that administration of nicotine in doses equivalent to smoking produced 200% (Pontieri et al., 1996) and 250% (Domino and Tsukada, 2009) increases in extracellular DA above basal level in the striatum of rats and monkeys, respectively. In studies of cocaine and amphetamine, which were shown to be able to increase DA anywhere from 250 to 1,000% in the rat striatum (Carboni et al., 2001) , the sensitivity of lpntPET to detect such DA activation with a lot greater magnitude would be much higher .
The timing of DA response in our simulations was assumed to take off as soon as the cigarette smoking started, and to rise to its peak height 10min after takeoff. This was typical of smoking one or two cigarettes based on estimated DA curves observed in our smoking study . In our curve fitting process, the search space for the response start times (t D ) was bounded between (smoking time -5 min) to (smoking time + 15 min). For PET experiments that involve drug challenges or behavioral tasks with different durations, the search space for response start times should be adjusted for the specific study. If the shape of the DA response induced by the drug/task is known to be different from the one we used, a tailored library of possible response functions specific to the drug/task should be constructed when implementing lp-ntPET.
The phantoms in this study were created by placing the simulated TACs into a 3D striatal template which contains 4 coronal slices and 1004 voxels in the MNI template space with a voxel size of 2 x 2 x 2 mm 3 . Since the phantoms were created and analyzed in the template space, the general conclusions in this study are not specific to our HRRT scanner. The absolute sensitivity values, though, are related to the noise level of the PET TACs which, in turn, depend on the characteristics of the PET scanner. For use with the HR+ scanner, which has lower spatial resolution (i.e., bigger voxel size) than the HRRT, the noise level of the TACs in individual voxels could be lower than our simulated noise level. The sensitivity of lp-ntPET to detect DA activation on the voxel level in less noisy PET data acquired by the HR+ scanner could be higher, but the chance of detecting small activated clusters could be lower due to the lower spatial resolution, i.e., if the activation locus is smaller than an HR+ voxel, then we'll miss the event entirely.
Conclusion
In this study, we optimized the design and pre-processing of PET studies using lp-ntPET analysis to detect short-lived DA release (such as we would expect from cigarette smoking) during a PET scan. Our simulations suggest that a Bolus paradigm could replace a more difficult B/I design and would not sacrifice the sensitivity of the method. The de-noising algorithm HYPR, in all circumstances, could improve the sensitivity of lp-ntPET. The optimal timing to start the smoking task is 45min in a 90min scan and 35min in a 75min scan. A mild shortening of the scan time from 90mCi to 75min should be acceptable without loss of sensitivity. We suggest setting the lower dose limit of a Bolus injection at 16mCi to limit possible underestimation of DA activation. Since the cluster size threshold to control the same false positive rate across different study paradigms must be varied, when designing a new lp-ntPET study, the cluster size threshold needs to be tailored for that specific study. We optimized the PET study design based on the shape of DA response that we believe applies to our smoking study. The general findings should apply to other studies that induce a similar DA response. If the shape of DA response induced by another challenge differs substantially from the one we used, additional simulations following the framework presented may be necessary.
